David Platt - May 11, 2022 Form 4 Insider Report for BIOXYTRAN, INC (BIXT)

Role
CEO, Director, 10%+ Owner
Signature
/s/ David Platt
Stock symbol
BIXT
Transactions as of
May 11, 2022
Transactions value $
-$43,920
Form type
4
Date filed
5/13/2022, 12:34 PM
Previous filing
Jan 28, 2022
Next filing
Aug 16, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIXT Warrants Gift -$43.9K -122K -100% $0.36 0 May 11, 2022 Common 122K $2.00 by NDPD Pharma, Inc. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The warrant agreement includes provisions for dilutive issuance and cash-less exercise